NSE filing, NSE: GENESYS. Summary written from the filing by ALFA Finder's alert engine.
Genesys International Corporation Ltd: key numbers
- Share price
- ₹190.33
- Market cap
- ₹1,273 Cr
- Revenue (annual)
- ₹327.8 Cr
- Net profit (annual)
- ₹32.58 Cr
- P/E (TTM)
- 41.3×Sector 23.7×
- Promoter holding
- 32.73%+1.23% QoQ
- FII holding
- 1.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genesys International Corporation Ltd
All →Genesys International Corporation Results Update
Genesys International reported Q2 FY27 revenue of ₹89.99 Crore and a PAT of ₹6.44 Crore. The press release highlights consolidated operational performance for the period.
Genesys International Corporation Q2 FY27 Results: Net Profit ₹6.5 Cr, Down 46.3% YoY
Genesys International Corporation Ltd reported revenue from operations of ₹87.9 Cr (+14.3% YoY) and net profit of ₹6.5 Cr (-46.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6.5 Cr · -46.3% YoY
Genesys International Corporation Board Meeting Date
Genesys International has given notice of a board meeting on 13-11-2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed until 15-11-2026, and no outcome exists yet.
Genesys International Corporation Other Announcement
Genesys International Corporation Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Genesys International Corporation Annual General Meeting
Genesys International Corporation held its 44th Annual General Meeting on September 30, 2026. Shareholders transacted ordinary and special business items as listed in the meeting notice.
Genesys International Corporation Bags ₹283 Cr Order from Ahmedabad Municipal Authority
Genesys International wins a ₹283 crore World Bank-funded contract for Ahmedabad's 3D Digital Twin platform. The project covers 625 sq km over two-and-a-half years.
- Value
- ₹283.0 Cr
- From
- Ahmedabad Municipal Authority (World Bank-funded, Gujarat Resilient Cities Partnership)
- Execution
- 2.5 years completion + 5 years operation & maintenance
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr